Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II

M. L. Garg, R. J. Blake, E. Clayton, I. A. Munro, L. MacDonald-Wicks, H. Singh, P. J. Moughan

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: Recent developments in micro-emulsification technology have allowed the fortification of foods with long-chain n-3 polyunsaturated fatty acid (PUFA) without the undesirable fish odour/taste and with reasonable shelf life. The effects of supplementing the diets of people with diabetes type II with a hummus-based dip enriched with long-chain n-3PUFA on plasma fatty acid composition and lipid levels were examined.

Design: A pre- and post-intervention study. Setting: This study was conducted at the University of Newcastle, Australia. Subjects: Participants were recruited via advertisements on the University of Newcastle notice boards and in the local newspapers. Following initial response to study advertisements, information statements were mailed out to 29 potential participants. Thirteen participants were eligible and consented to participate in the trial. There were no dropouts as all the 13 participants completed 6-week intervention trial.

Methods: Free-living male and female subjects with diabetes type II (n = 13) consumed the n-3PUFA-enriched dip for a period of 6 weeks. Fasting blood samples were collected pre- and post-intervention for analyses of fatty acids and plasma lipids. Results: Following 6 weeks of consuming the enriched dip, all the long-chain n-3PUFA (20:5n-3, 22:5n-3 and 22:6n-3) were significantly (P < 0.05) elevated in the plasma lipids. This represented an increase in 20:5n-3 content by 117% increase in 22:5n-3 content by 15% and an increase in 22:6n-3 content by 80% over the baseline values before dip consumption. A significant reduction (P < 0.05) in the plasma triglyceride levels from 1.93 (1.08-2.09)mmol/l at baseline to 1.27 (0.93-2.22)mmol/l after 6 weeks was also apparent following the consumption of the n-3PUFA-enriched dip. Plasma cholesterol was unchanged; however, low-density lipoprotein (LDL)-cholesterol (2.46 ± 0.21 versus 2.72 ± 0.22 ± mmol/l, P < 0.034) and high-density lipoprotein (HDL)-cholesterol (1.16 ± 0.09 versus 1.22 ± 0.09mmol/l, P < 0.042) were significantly increased following the dietary intervention. Conclusions: These results demonstrate that n-3PUFA are readily bioavailable from the fortified dip matrix and alter the plasma lipid profile.

Original languageEnglish
Pages (from-to)1312-1317
Number of pages6
JournalEuropean Journal of Clinical Nutrition
Volume61
Issue number11
DOIs
Publication statusPublished - 01 Nov 2007

Fingerprint

Omega-3 Fatty Acids
Type 2 Diabetes Mellitus
Lipids
Fatty Acids
Newspapers
LDL Cholesterol
HDL Cholesterol
Fasting
Fishes
Triglycerides
Cholesterol
Diet
Technology
Food

Cite this

Garg, M. L. ; Blake, R. J. ; Clayton, E. ; Munro, I. A. ; MacDonald-Wicks, L. ; Singh, H. ; Moughan, P. J. / Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. In: European Journal of Clinical Nutrition. 2007 ; Vol. 61, No. 11. pp. 1312-1317.
@article{2b178eb296fe471e8cffb04d719f0de4,
title = "Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II",
abstract = "Objective: Recent developments in micro-emulsification technology have allowed the fortification of foods with long-chain n-3 polyunsaturated fatty acid (PUFA) without the undesirable fish odour/taste and with reasonable shelf life. The effects of supplementing the diets of people with diabetes type II with a hummus-based dip enriched with long-chain n-3PUFA on plasma fatty acid composition and lipid levels were examined. Design: A pre- and post-intervention study. Setting: This study was conducted at the University of Newcastle, Australia. Subjects: Participants were recruited via advertisements on the University of Newcastle notice boards and in the local newspapers. Following initial response to study advertisements, information statements were mailed out to 29 potential participants. Thirteen participants were eligible and consented to participate in the trial. There were no dropouts as all the 13 participants completed 6-week intervention trial. Methods: Free-living male and female subjects with diabetes type II (n = 13) consumed the n-3PUFA-enriched dip for a period of 6 weeks. Fasting blood samples were collected pre- and post-intervention for analyses of fatty acids and plasma lipids. Results: Following 6 weeks of consuming the enriched dip, all the long-chain n-3PUFA (20:5n-3, 22:5n-3 and 22:6n-3) were significantly (P < 0.05) elevated in the plasma lipids. This represented an increase in 20:5n-3 content by 117{\%} increase in 22:5n-3 content by 15{\%} and an increase in 22:6n-3 content by 80{\%} over the baseline values before dip consumption. A significant reduction (P < 0.05) in the plasma triglyceride levels from 1.93 (1.08-2.09)mmol/l at baseline to 1.27 (0.93-2.22)mmol/l after 6 weeks was also apparent following the consumption of the n-3PUFA-enriched dip. Plasma cholesterol was unchanged; however, low-density lipoprotein (LDL)-cholesterol (2.46 ± 0.21 versus 2.72 ± 0.22 ± mmol/l, P < 0.034) and high-density lipoprotein (HDL)-cholesterol (1.16 ± 0.09 versus 1.22 ± 0.09mmol/l, P < 0.042) were significantly increased following the dietary intervention. Conclusions: These results demonstrate that n-3PUFA are readily bioavailable from the fortified dip matrix and alter the plasma lipid profile.",
author = "Garg, {M. L.} and Blake, {R. J.} and E. Clayton and Munro, {I. A.} and L. MacDonald-Wicks and H. Singh and Moughan, {P. J.}",
year = "2007",
month = "11",
day = "1",
doi = "10.1038/sj.ejcn.1602650",
language = "English",
volume = "61",
pages = "1312--1317",
journal = "European Journal of Clinical Nutrition",
issn = "0954-3007",
publisher = "Nature Publishing Group",
number = "11",

}

Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II. / Garg, M. L.; Blake, R. J.; Clayton, E.; Munro, I. A.; MacDonald-Wicks, L.; Singh, H.; Moughan, P. J.

In: European Journal of Clinical Nutrition, Vol. 61, No. 11, 01.11.2007, p. 1312-1317.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II

AU - Garg, M. L.

AU - Blake, R. J.

AU - Clayton, E.

AU - Munro, I. A.

AU - MacDonald-Wicks, L.

AU - Singh, H.

AU - Moughan, P. J.

PY - 2007/11/1

Y1 - 2007/11/1

N2 - Objective: Recent developments in micro-emulsification technology have allowed the fortification of foods with long-chain n-3 polyunsaturated fatty acid (PUFA) without the undesirable fish odour/taste and with reasonable shelf life. The effects of supplementing the diets of people with diabetes type II with a hummus-based dip enriched with long-chain n-3PUFA on plasma fatty acid composition and lipid levels were examined. Design: A pre- and post-intervention study. Setting: This study was conducted at the University of Newcastle, Australia. Subjects: Participants were recruited via advertisements on the University of Newcastle notice boards and in the local newspapers. Following initial response to study advertisements, information statements were mailed out to 29 potential participants. Thirteen participants were eligible and consented to participate in the trial. There were no dropouts as all the 13 participants completed 6-week intervention trial. Methods: Free-living male and female subjects with diabetes type II (n = 13) consumed the n-3PUFA-enriched dip for a period of 6 weeks. Fasting blood samples were collected pre- and post-intervention for analyses of fatty acids and plasma lipids. Results: Following 6 weeks of consuming the enriched dip, all the long-chain n-3PUFA (20:5n-3, 22:5n-3 and 22:6n-3) were significantly (P < 0.05) elevated in the plasma lipids. This represented an increase in 20:5n-3 content by 117% increase in 22:5n-3 content by 15% and an increase in 22:6n-3 content by 80% over the baseline values before dip consumption. A significant reduction (P < 0.05) in the plasma triglyceride levels from 1.93 (1.08-2.09)mmol/l at baseline to 1.27 (0.93-2.22)mmol/l after 6 weeks was also apparent following the consumption of the n-3PUFA-enriched dip. Plasma cholesterol was unchanged; however, low-density lipoprotein (LDL)-cholesterol (2.46 ± 0.21 versus 2.72 ± 0.22 ± mmol/l, P < 0.034) and high-density lipoprotein (HDL)-cholesterol (1.16 ± 0.09 versus 1.22 ± 0.09mmol/l, P < 0.042) were significantly increased following the dietary intervention. Conclusions: These results demonstrate that n-3PUFA are readily bioavailable from the fortified dip matrix and alter the plasma lipid profile.

AB - Objective: Recent developments in micro-emulsification technology have allowed the fortification of foods with long-chain n-3 polyunsaturated fatty acid (PUFA) without the undesirable fish odour/taste and with reasonable shelf life. The effects of supplementing the diets of people with diabetes type II with a hummus-based dip enriched with long-chain n-3PUFA on plasma fatty acid composition and lipid levels were examined. Design: A pre- and post-intervention study. Setting: This study was conducted at the University of Newcastle, Australia. Subjects: Participants were recruited via advertisements on the University of Newcastle notice boards and in the local newspapers. Following initial response to study advertisements, information statements were mailed out to 29 potential participants. Thirteen participants were eligible and consented to participate in the trial. There were no dropouts as all the 13 participants completed 6-week intervention trial. Methods: Free-living male and female subjects with diabetes type II (n = 13) consumed the n-3PUFA-enriched dip for a period of 6 weeks. Fasting blood samples were collected pre- and post-intervention for analyses of fatty acids and plasma lipids. Results: Following 6 weeks of consuming the enriched dip, all the long-chain n-3PUFA (20:5n-3, 22:5n-3 and 22:6n-3) were significantly (P < 0.05) elevated in the plasma lipids. This represented an increase in 20:5n-3 content by 117% increase in 22:5n-3 content by 15% and an increase in 22:6n-3 content by 80% over the baseline values before dip consumption. A significant reduction (P < 0.05) in the plasma triglyceride levels from 1.93 (1.08-2.09)mmol/l at baseline to 1.27 (0.93-2.22)mmol/l after 6 weeks was also apparent following the consumption of the n-3PUFA-enriched dip. Plasma cholesterol was unchanged; however, low-density lipoprotein (LDL)-cholesterol (2.46 ± 0.21 versus 2.72 ± 0.22 ± mmol/l, P < 0.034) and high-density lipoprotein (HDL)-cholesterol (1.16 ± 0.09 versus 1.22 ± 0.09mmol/l, P < 0.042) were significantly increased following the dietary intervention. Conclusions: These results demonstrate that n-3PUFA are readily bioavailable from the fortified dip matrix and alter the plasma lipid profile.

UR - http://www.scopus.com/inward/record.url?scp=35748941343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748941343&partnerID=8YFLogxK

U2 - 10.1038/sj.ejcn.1602650

DO - 10.1038/sj.ejcn.1602650

M3 - Article

C2 - 17299483

AN - SCOPUS:35748941343

VL - 61

SP - 1312

EP - 1317

JO - European Journal of Clinical Nutrition

JF - European Journal of Clinical Nutrition

SN - 0954-3007

IS - 11

ER -